Switch to:
GuruFocus has detected 1 Warning Sign with Biomarin Pharmaceutical Inc $BMRN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Biomarin Pharmaceutical Inc (NAS:BMRN)
Cash Flow from Others
$560 Mil (TTM As of Mar. 2017)

Biomarin Pharmaceutical Inc's cash flow from others for the three months ended in Mar. 2017 was $6 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2017 was $560 Mil.


Definition

Biomarin Pharmaceutical Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2017 was 545.302 (Jun. 2016 ) + 6.77 (Sep. 2016 ) + 2.49 (Dec. 2016 ) + 5.759 (Mar. 2017 ) = $560 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others -731120141736-27-176559

Biomarin Pharmaceutical Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow from Others 81282-2085545726
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK